抑郁症状与心力衰竭的临床结果有关,心力衰竭的临床结果与减少的喷射分数有关
Andrew Sherwood1, James A Blumenthal1, Robert J Mentz2
1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.
ESC heart failure
|May 8, 2024
概括
心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭中心力衰竭. 糟糕的健康行为可能会使这种关联变得更糟,强调需要综合护理.
科学领域:
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
- 临床医学 临床医学
背景情况:
- 减少喷射分数 (HFrEF) 的心力衰竭是一个重大的临床挑战.
- 抑郁症状在HFrEF患者中很常见,并且与较差的结果有关.
- 在HFrEF中抑郁症,健康行为和临床事件之间的相互作用需要进一步调查.
研究的目的:
- 检查HFrEF患者中抑郁症状升高和不良临床事件之间的关联.
- 调查健康行为对这种关联的潜在贡献.
主要方法:
- 招募了142名HFrEF患者,并随着时间的推移进行了跟踪.
- 评估了抑郁症症状 (贝克抑郁症目录-II),HF自我护理 (SCHFI) 和每天的步骤.
- 监测疾病活性 (B型尿素) 和临床结果 (死亡,心血管住院).
主要成果:
- 抑郁症状得分增加10个点与死亡或心血管住院风险增加35%相关.
- 较高的抑郁症状与较差的自我护理维护和减少每天步骤有关.
- 在6个月内B型尿素的增加预测了更糟糕的结果,并且与抑郁症状的变化有关.
结论:
- 高度抑郁症状被证实是HFrEF患者不良临床结果的重要风险因素.
- 糟糕的健康行为可能会调解这种人群中抑郁症和临床结果之间的不良联系.
- 综合管理解决心理健康和自我护理行为对于改善HFrEF患者的结果至关重要.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Depressive Disorders: Etiology
69
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
69
Depressive Disorders: MDD and Dysthymia
102
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
102
Depression: Overview
241
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
241
Negative and Cognitive Symptoms of Schizophrenia
48
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
48
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422


